Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About DMD
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About DMD
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

September 01, 2015; Volume 43,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ajamie, Rose T.

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745
  2. Azuma, Yoshiaki

    1. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      You have access
      SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      Wenqi Cui, Mengxi Sun, Nadezhda Galeva, Todd D. Williams, Yoshiaki Azuma and Jeff L. Staudinger
      Drug Metabolism and Disposition September 2015, 43 (9) 1316-1325; DOI: https://doi.org/10.1124/dmd.115.065201

B

  1. Barbara, Joanna E.

    1. You have access
      Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor
      Faraz Kazmi, Phyllis Yerino, Joanna E. Barbara and Andrew Parkinson
      Drug Metabolism and Disposition September 2015, 43 (9) 1294-1302; DOI: https://doi.org/10.1124/dmd.115.065011
  2. Bian, Yicong

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717
  3. Boucaut, David

    1. You have access
      Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist
      Hugues Chanteux, Ludovicus Staelens, Valérie Mancel, Brigitte Gerin, David Boucaut, Chandra Prakash and Jean-Marie Nicolas
      Drug Metabolism and Disposition September 2015, 43 (9) 1381-1391; DOI: https://doi.org/10.1124/dmd.115.064436
  4. Bromek, Ewa

    1. You have access
      Damage to the Brain Serotonergic System Increases the Expression of Liver Cytochrome P450
      Marta Rysz, Ewa Bromek, Anna Haduch, Anna Sadakierska-Chudy and Władysława A. Daniel
      Drug Metabolism and Disposition September 2015, 43 (9) 1345-1352; DOI: https://doi.org/10.1124/dmd.115.064980

C

  1. Caron, Patrick

    1. You have access
      Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
      Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, John K. Fallon, Patrick Caron, Lyne Villeneuve, Philip C. Smith, Ulrich M. Zanger and Chantal Guillemette
      Drug Metabolism and Disposition September 2015, 43 (9) 1331-1335; DOI: https://doi.org/10.1124/dmd.115.065391
  2. Chanteux, Hugues

    1. You have access
      Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist
      Hugues Chanteux, Ludovicus Staelens, Valérie Mancel, Brigitte Gerin, David Boucaut, Chandra Prakash and Jean-Marie Nicolas
      Drug Metabolism and Disposition September 2015, 43 (9) 1381-1391; DOI: https://doi.org/10.1124/dmd.115.064436
  3. Chen, Gang

    1. You have access
      Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product–Drug Interaction
      Brandon T. Gufford, Gang Chen, Ana G. Vergara, Philip Lazarus, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2015, 43 (9) 1353-1359; DOI: https://doi.org/10.1124/dmd.115.065086
  4. Cui, Wenqi

    1. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      You have access
      SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      Wenqi Cui, Mengxi Sun, Nadezhda Galeva, Todd D. Williams, Yoshiaki Azuma and Jeff L. Staudinger
      Drug Metabolism and Disposition September 2015, 43 (9) 1316-1325; DOI: https://doi.org/10.1124/dmd.115.065201

D

  1. Daniel, Władysława A.

    1. You have access
      Damage to the Brain Serotonergic System Increases the Expression of Liver Cytochrome P450
      Marta Rysz, Ewa Bromek, Anna Haduch, Anna Sadakierska-Chudy and Władysława A. Daniel
      Drug Metabolism and Disposition September 2015, 43 (9) 1345-1352; DOI: https://doi.org/10.1124/dmd.115.064980
  2. De Dios, Alfonso

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745
  3. Ding, Xinxin

    1. You have access
      Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms
      Lindsay B. Hough, Julia W. Nalwalk, Xinxin Ding and Nico Scheer
      Drug Metabolism and Disposition September 2015, 43 (9) 1326-1330; DOI: https://doi.org/10.1124/dmd.115.065490

F

  1. Fallon, John K.

    1. You have access
      Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
      Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, John K. Fallon, Patrick Caron, Lyne Villeneuve, Philip C. Smith, Ulrich M. Zanger and Chantal Guillemette
      Drug Metabolism and Disposition September 2015, 43 (9) 1331-1335; DOI: https://doi.org/10.1124/dmd.115.065391
  2. Fanslow, William C.

    1. You have access
      Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker
      Brooke M. Rock, Mark E. Tometsko, Sonal K. Patel, Kevin J. Hamblett, William C. Fanslow and Dan A. Rock
      Drug Metabolism and Disposition September 2015, 43 (9) 1341-1344; DOI: https://doi.org/10.1124/dmd.115.064253

G

  1. Galeva, Nadezhda

    1. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      You have access
      SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      Wenqi Cui, Mengxi Sun, Nadezhda Galeva, Todd D. Williams, Yoshiaki Azuma and Jeff L. Staudinger
      Drug Metabolism and Disposition September 2015, 43 (9) 1316-1325; DOI: https://doi.org/10.1124/dmd.115.065201
  2. Gelbert, Lawrence M.

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745
  3. Gerin, Brigitte

    1. You have access
      Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist
      Hugues Chanteux, Ludovicus Staelens, Valérie Mancel, Brigitte Gerin, David Boucaut, Chandra Prakash and Jean-Marie Nicolas
      Drug Metabolism and Disposition September 2015, 43 (9) 1381-1391; DOI: https://doi.org/10.1124/dmd.115.064436
  4. Goldman, Jennifer L.

    1. You have access
      In Vitro Hepatic Oxidative Biotransformation of Trimethoprim
      Jennifer L. Goldman, J. Steven Leeder, Leon Van Haandel and Robin E. Pearce
      Drug Metabolism and Disposition September 2015, 43 (9) 1372-1380; DOI: https://doi.org/10.1124/dmd.115.065193
  5. Gufford, Brandon T.

    1. You have access
      Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product–Drug Interaction
      Brandon T. Gufford, Gang Chen, Ana G. Vergara, Philip Lazarus, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2015, 43 (9) 1353-1359; DOI: https://doi.org/10.1124/dmd.115.065086
  6. Guillemette, Chantal

    1. You have access
      Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
      Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, John K. Fallon, Patrick Caron, Lyne Villeneuve, Philip C. Smith, Ulrich M. Zanger and Chantal Guillemette
      Drug Metabolism and Disposition September 2015, 43 (9) 1331-1335; DOI: https://doi.org/10.1124/dmd.115.065391
  7. Guo, Kenan

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717

H

  1. Haduch, Anna

    1. You have access
      Damage to the Brain Serotonergic System Increases the Expression of Liver Cytochrome P450
      Marta Rysz, Ewa Bromek, Anna Haduch, Anna Sadakierska-Chudy and Władysława A. Daniel
      Drug Metabolism and Disposition September 2015, 43 (9) 1345-1352; DOI: https://doi.org/10.1124/dmd.115.064980
  2. Hamblett, Kevin J.

    1. You have access
      Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker
      Brooke M. Rock, Mark E. Tometsko, Sonal K. Patel, Kevin J. Hamblett, William C. Fanslow and Dan A. Rock
      Drug Metabolism and Disposition September 2015, 43 (9) 1341-1344; DOI: https://doi.org/10.1124/dmd.115.064253
  3. Hough, Lindsay B.

    1. You have access
      Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms
      Lindsay B. Hough, Julia W. Nalwalk, Xinxin Ding and Nico Scheer
      Drug Metabolism and Disposition September 2015, 43 (9) 1326-1330; DOI: https://doi.org/10.1124/dmd.115.065490
  4. Hu, Haihong

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717

J

  1. Jiang, Huidi

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717

K

  1. Kazmi, Faraz

    1. You have access
      Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor
      Faraz Kazmi, Phyllis Yerino, Joanna E. Barbara and Andrew Parkinson
      Drug Metabolism and Disposition September 2015, 43 (9) 1294-1302; DOI: https://doi.org/10.1124/dmd.115.065011
  2. Kitagawara, Yumina

    1. You have access
      Novel Bioactivation Pathway of Benzbromarone Mediated by Cytochrome P450
      Yumina Kitagawara, Tomoyuki Ohe, Kumiko Tachibana, Kyoko Takahashi, Shigeo Nakamura and Tadahiko Mashino
      Drug Metabolism and Disposition September 2015, 43 (9) 1303-1306; DOI: https://doi.org/10.1124/dmd.115.065037
  3. Klein, Kathrin

    1. You have access
      Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
      Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, John K. Fallon, Patrick Caron, Lyne Villeneuve, Philip C. Smith, Ulrich M. Zanger and Chantal Guillemette
      Drug Metabolism and Disposition September 2015, 43 (9) 1331-1335; DOI: https://doi.org/10.1124/dmd.115.065391
  4. Kulanthaivel, Palaniappan

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745

L

  1. Lazarus, Philip

    1. You have access
      Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product–Drug Interaction
      Brandon T. Gufford, Gang Chen, Ana G. Vergara, Philip Lazarus, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2015, 43 (9) 1353-1359; DOI: https://doi.org/10.1124/dmd.115.065086
  2. Leeder, J. Steven

    1. You have access
      In Vitro Hepatic Oxidative Biotransformation of Trimethoprim
      Jennifer L. Goldman, J. Steven Leeder, Leon Van Haandel and Robin E. Pearce
      Drug Metabolism and Disposition September 2015, 43 (9) 1372-1380; DOI: https://doi.org/10.1124/dmd.115.065193
  3. Lei, Jinxiu

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717
  4. Li, Hui

    1. You have access
      Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study
      Michael J. Myers, Marilyn Martinez, Hui Li, Junshan Qiu, Lisa Troutman, Michele Sharkey and Haile F. Yancy
      Drug Metabolism and Disposition September 2015, 43 (9) 1392-1407; DOI: https://doi.org/10.1124/dmd.115.063735

M

  1. Mancel, Valérie

    1. You have access
      Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist
      Hugues Chanteux, Ludovicus Staelens, Valérie Mancel, Brigitte Gerin, David Boucaut, Chandra Prakash and Jean-Marie Nicolas
      Drug Metabolism and Disposition September 2015, 43 (9) 1381-1391; DOI: https://doi.org/10.1124/dmd.115.064436
  2. Margaillan, Guillaume

    1. You have access
      Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
      Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, John K. Fallon, Patrick Caron, Lyne Villeneuve, Philip C. Smith, Ulrich M. Zanger and Chantal Guillemette
      Drug Metabolism and Disposition September 2015, 43 (9) 1331-1335; DOI: https://doi.org/10.1124/dmd.115.065391
  3. Martinez, Marilyn

    1. You have access
      Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study
      Michael J. Myers, Marilyn Martinez, Hui Li, Junshan Qiu, Lisa Troutman, Michele Sharkey and Haile F. Yancy
      Drug Metabolism and Disposition September 2015, 43 (9) 1392-1407; DOI: https://doi.org/10.1124/dmd.115.063735
  4. Mashino, Tadahiko

    1. You have access
      Novel Bioactivation Pathway of Benzbromarone Mediated by Cytochrome P450
      Yumina Kitagawara, Tomoyuki Ohe, Kumiko Tachibana, Kyoko Takahashi, Shigeo Nakamura and Tadahiko Mashino
      Drug Metabolism and Disposition September 2015, 43 (9) 1303-1306; DOI: https://doi.org/10.1124/dmd.115.065037
  5. Myers, Michael J.

    1. You have access
      Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study
      Michael J. Myers, Marilyn Martinez, Hui Li, Junshan Qiu, Lisa Troutman, Michele Sharkey and Haile F. Yancy
      Drug Metabolism and Disposition September 2015, 43 (9) 1392-1407; DOI: https://doi.org/10.1124/dmd.115.063735

N

  1. Nakamura, Shigeo

    1. You have access
      Novel Bioactivation Pathway of Benzbromarone Mediated by Cytochrome P450
      Yumina Kitagawara, Tomoyuki Ohe, Kumiko Tachibana, Kyoko Takahashi, Shigeo Nakamura and Tadahiko Mashino
      Drug Metabolism and Disposition September 2015, 43 (9) 1303-1306; DOI: https://doi.org/10.1124/dmd.115.065037
  2. Nalwalk, Julia W.

    1. You have access
      Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms
      Lindsay B. Hough, Julia W. Nalwalk, Xinxin Ding and Nico Scheer
      Drug Metabolism and Disposition September 2015, 43 (9) 1326-1330; DOI: https://doi.org/10.1124/dmd.115.065490
  3. Nicolas, Jean-Marie

    1. You have access
      Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist
      Hugues Chanteux, Ludovicus Staelens, Valérie Mancel, Brigitte Gerin, David Boucaut, Chandra Prakash and Jean-Marie Nicolas
      Drug Metabolism and Disposition September 2015, 43 (9) 1381-1391; DOI: https://doi.org/10.1124/dmd.115.064436

O

  1. Oberlies, Nicholas H.

    1. You have access
      Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product–Drug Interaction
      Brandon T. Gufford, Gang Chen, Ana G. Vergara, Philip Lazarus, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2015, 43 (9) 1353-1359; DOI: https://doi.org/10.1124/dmd.115.065086
  2. Ohe, Tomoyuki

    1. You have access
      Novel Bioactivation Pathway of Benzbromarone Mediated by Cytochrome P450
      Yumina Kitagawara, Tomoyuki Ohe, Kumiko Tachibana, Kyoko Takahashi, Shigeo Nakamura and Tadahiko Mashino
      Drug Metabolism and Disposition September 2015, 43 (9) 1303-1306; DOI: https://doi.org/10.1124/dmd.115.065037

P

  1. Paine, Mary F.

    1. You have access
      Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product–Drug Interaction
      Brandon T. Gufford, Gang Chen, Ana G. Vergara, Philip Lazarus, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2015, 43 (9) 1353-1359; DOI: https://doi.org/10.1124/dmd.115.065086
  2. Parkinson, Andrew

    1. You have access
      Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor
      Faraz Kazmi, Phyllis Yerino, Joanna E. Barbara and Andrew Parkinson
      Drug Metabolism and Disposition September 2015, 43 (9) 1294-1302; DOI: https://doi.org/10.1124/dmd.115.065011
  3. Patel, Sonal K.

    1. You have access
      Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker
      Brooke M. Rock, Mark E. Tometsko, Sonal K. Patel, Kevin J. Hamblett, William C. Fanslow and Dan A. Rock
      Drug Metabolism and Disposition September 2015, 43 (9) 1341-1344; DOI: https://doi.org/10.1124/dmd.115.064253
  4. Pearce, Robin E.

    1. You have access
      In Vitro Hepatic Oxidative Biotransformation of Trimethoprim
      Jennifer L. Goldman, J. Steven Leeder, Leon Van Haandel and Robin E. Pearce
      Drug Metabolism and Disposition September 2015, 43 (9) 1372-1380; DOI: https://doi.org/10.1124/dmd.115.065193
  5. Prakash, Chandra

    1. You have access
      Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist
      Hugues Chanteux, Ludovicus Staelens, Valérie Mancel, Brigitte Gerin, David Boucaut, Chandra Prakash and Jean-Marie Nicolas
      Drug Metabolism and Disposition September 2015, 43 (9) 1381-1391; DOI: https://doi.org/10.1124/dmd.115.064436

Q

  1. Qiu, Junshan

    1. You have access
      Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study
      Michael J. Myers, Marilyn Martinez, Hui Li, Junshan Qiu, Lisa Troutman, Michele Sharkey and Haile F. Yancy
      Drug Metabolism and Disposition September 2015, 43 (9) 1392-1407; DOI: https://doi.org/10.1124/dmd.115.063735

R

  1. Ramsden, Diane

    1. You have access
      Determination of a Degradation Constant for CYP3A4 by Direct Suppression of mRNA in a Novel Human Hepatocyte Model, HepatoPac
      Diane Ramsden, Jin Zhou and Donald J. Tweedie
      Drug Metabolism and Disposition September 2015, 43 (9) 1307-1315; DOI: https://doi.org/10.1124/dmd.115.065326
  2. Raub, Thomas J.

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745
  3. Rock, Brooke M.

    1. You have access
      Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker
      Brooke M. Rock, Mark E. Tometsko, Sonal K. Patel, Kevin J. Hamblett, William C. Fanslow and Dan A. Rock
      Drug Metabolism and Disposition September 2015, 43 (9) 1341-1344; DOI: https://doi.org/10.1124/dmd.115.064253
  4. Rock, Dan A.

    1. You have access
      Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker
      Brooke M. Rock, Mark E. Tometsko, Sonal K. Patel, Kevin J. Hamblett, William C. Fanslow and Dan A. Rock
      Drug Metabolism and Disposition September 2015, 43 (9) 1341-1344; DOI: https://doi.org/10.1124/dmd.115.064253
  5. Rouleau, Michèle

    1. You have access
      Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
      Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, John K. Fallon, Patrick Caron, Lyne Villeneuve, Philip C. Smith, Ulrich M. Zanger and Chantal Guillemette
      Drug Metabolism and Disposition September 2015, 43 (9) 1331-1335; DOI: https://doi.org/10.1124/dmd.115.065391
  6. Rysz, Marta

    1. You have access
      Damage to the Brain Serotonergic System Increases the Expression of Liver Cytochrome P450
      Marta Rysz, Ewa Bromek, Anna Haduch, Anna Sadakierska-Chudy and Władysława A. Daniel
      Drug Metabolism and Disposition September 2015, 43 (9) 1345-1352; DOI: https://doi.org/10.1124/dmd.115.064980

S

  1. Sadakierska-Chudy, Anna

    1. You have access
      Damage to the Brain Serotonergic System Increases the Expression of Liver Cytochrome P450
      Marta Rysz, Ewa Bromek, Anna Haduch, Anna Sadakierska-Chudy and Władysława A. Daniel
      Drug Metabolism and Disposition September 2015, 43 (9) 1345-1352; DOI: https://doi.org/10.1124/dmd.115.064980
  2. Sanchez-Martinez, Concepcion

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745
  3. Sawada, Geri A.

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745
  4. Scheer, Nico

    1. You have access
      Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms
      Lindsay B. Hough, Julia W. Nalwalk, Xinxin Ding and Nico Scheer
      Drug Metabolism and Disposition September 2015, 43 (9) 1326-1330; DOI: https://doi.org/10.1124/dmd.115.065490
  5. Shang, Haitao

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717
  6. Shannon, Harlan E.

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745
  7. Sharkey, Michele

    1. You have access
      Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study
      Michael J. Myers, Marilyn Martinez, Hui Li, Junshan Qiu, Lisa Troutman, Michele Sharkey and Haile F. Yancy
      Drug Metabolism and Disposition September 2015, 43 (9) 1392-1407; DOI: https://doi.org/10.1124/dmd.115.063735
  8. Smith, Philip C.

    1. You have access
      Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
      Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, John K. Fallon, Patrick Caron, Lyne Villeneuve, Philip C. Smith, Ulrich M. Zanger and Chantal Guillemette
      Drug Metabolism and Disposition September 2015, 43 (9) 1331-1335; DOI: https://doi.org/10.1124/dmd.115.065391
  9. Staelens, Ludovicus

    1. You have access
      Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist
      Hugues Chanteux, Ludovicus Staelens, Valérie Mancel, Brigitte Gerin, David Boucaut, Chandra Prakash and Jean-Marie Nicolas
      Drug Metabolism and Disposition September 2015, 43 (9) 1381-1391; DOI: https://doi.org/10.1124/dmd.115.064436
  10. Staton, Brian A.

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745
  11. Staudinger, Jeff L.

    1. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      You have access
      SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      Wenqi Cui, Mengxi Sun, Nadezhda Galeva, Todd D. Williams, Yoshiaki Azuma and Jeff L. Staudinger
      Drug Metabolism and Disposition September 2015, 43 (9) 1316-1325; DOI: https://doi.org/10.1124/dmd.115.065201
  12. Sun, Mengxi

    1. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      You have access
      SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      Wenqi Cui, Mengxi Sun, Nadezhda Galeva, Todd D. Williams, Yoshiaki Azuma and Jeff L. Staudinger
      Drug Metabolism and Disposition September 2015, 43 (9) 1316-1325; DOI: https://doi.org/10.1124/dmd.115.065201

T

  1. Tachibana, Kumiko

    1. You have access
      Novel Bioactivation Pathway of Benzbromarone Mediated by Cytochrome P450
      Yumina Kitagawara, Tomoyuki Ohe, Kumiko Tachibana, Kyoko Takahashi, Shigeo Nakamura and Tadahiko Mashino
      Drug Metabolism and Disposition September 2015, 43 (9) 1303-1306; DOI: https://doi.org/10.1124/dmd.115.065037
  2. Takahashi, Kyoko

    1. You have access
      Novel Bioactivation Pathway of Benzbromarone Mediated by Cytochrome P450
      Yumina Kitagawara, Tomoyuki Ohe, Kumiko Tachibana, Kyoko Takahashi, Shigeo Nakamura and Tadahiko Mashino
      Drug Metabolism and Disposition September 2015, 43 (9) 1303-1306; DOI: https://doi.org/10.1124/dmd.115.065037
  3. Tometsko, Mark E.

    1. You have access
      Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker
      Brooke M. Rock, Mark E. Tometsko, Sonal K. Patel, Kevin J. Hamblett, William C. Fanslow and Dan A. Rock
      Drug Metabolism and Disposition September 2015, 43 (9) 1341-1344; DOI: https://doi.org/10.1124/dmd.115.064253
  4. Troutman, Lisa

    1. You have access
      Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study
      Michael J. Myers, Marilyn Martinez, Hui Li, Junshan Qiu, Lisa Troutman, Michele Sharkey and Haile F. Yancy
      Drug Metabolism and Disposition September 2015, 43 (9) 1392-1407; DOI: https://doi.org/10.1124/dmd.115.063735
  5. Tweedie, Donald J.

    1. You have access
      Determination of a Degradation Constant for CYP3A4 by Direct Suppression of mRNA in a Novel Human Hepatocyte Model, HepatoPac
      Diane Ramsden, Jin Zhou and Donald J. Tweedie
      Drug Metabolism and Disposition September 2015, 43 (9) 1307-1315; DOI: https://doi.org/10.1124/dmd.115.065326

V

  1. Van Haandel, Leon

    1. You have access
      In Vitro Hepatic Oxidative Biotransformation of Trimethoprim
      Jennifer L. Goldman, J. Steven Leeder, Leon Van Haandel and Robin E. Pearce
      Drug Metabolism and Disposition September 2015, 43 (9) 1372-1380; DOI: https://doi.org/10.1124/dmd.115.065193
  2. Vergara, Ana G.

    1. You have access
      Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product–Drug Interaction
      Brandon T. Gufford, Gang Chen, Ana G. Vergara, Philip Lazarus, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2015, 43 (9) 1353-1359; DOI: https://doi.org/10.1124/dmd.115.065086
  3. Villeneuve, Lyne

    1. You have access
      Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
      Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, John K. Fallon, Patrick Caron, Lyne Villeneuve, Philip C. Smith, Ulrich M. Zanger and Chantal Guillemette
      Drug Metabolism and Disposition September 2015, 43 (9) 1331-1335; DOI: https://doi.org/10.1124/dmd.115.065391

W

  1. Wei, Hong

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717
  2. Williams, Todd D.

    1. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      You have access
      SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes
      Wenqi Cui, Mengxi Sun, Nadezhda Galeva, Todd D. Williams, Yoshiaki Azuma and Jeff L. Staudinger
      Drug Metabolism and Disposition September 2015, 43 (9) 1316-1325; DOI: https://doi.org/10.1124/dmd.115.065201
  3. Wishart, Graham N.

    1. You have access
      Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
      Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez and Alfonso De Dios
      Drug Metabolism and Disposition September 2015, 43 (9) 1360-1371; DOI: https://doi.org/10.1124/dmd.114.062745

Y

  1. Yancy, Haile F.

    1. You have access
      Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study
      Michael J. Myers, Marilyn Martinez, Hui Li, Junshan Qiu, Lisa Troutman, Michele Sharkey and Haile F. Yancy
      Drug Metabolism and Disposition September 2015, 43 (9) 1392-1407; DOI: https://doi.org/10.1124/dmd.115.063735
  2. Yao, Qingqing

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717
  3. Yerino, Phyllis

    1. You have access
      Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor
      Faraz Kazmi, Phyllis Yerino, Joanna E. Barbara and Andrew Parkinson
      Drug Metabolism and Disposition September 2015, 43 (9) 1294-1302; DOI: https://doi.org/10.1124/dmd.115.065011
  4. Yu, Lushan

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717

Z

  1. Zanger, Ulrich M.

    1. You have access
      Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential
      Guillaume Margaillan, Michèle Rouleau, Kathrin Klein, John K. Fallon, Patrick Caron, Lyne Villeneuve, Philip C. Smith, Ulrich M. Zanger and Chantal Guillemette
      Drug Metabolism and Disposition September 2015, 43 (9) 1331-1335; DOI: https://doi.org/10.1124/dmd.115.065391
  2. Zeng, Su

    1. You have access
      Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
      Yicong Bian, Qingqing Yao, Haitao Shang, Jinxiu Lei, Haihong Hu, Kenan Guo, Huidi Jiang, Lushan Yu, Hong Wei and Su Zeng
      Drug Metabolism and Disposition September 2015, 43 (9) 1336-1340; DOI: https://doi.org/10.1124/dmd.115.064717
  3. Zhou, Jin

    1. You have access
      Determination of a Degradation Constant for CYP3A4 by Direct Suppression of mRNA in a Novel Human Hepatocyte Model, HepatoPac
      Diane Ramsden, Jin Zhou and Donald J. Tweedie
      Drug Metabolism and Disposition September 2015, 43 (9) 1307-1315; DOI: https://doi.org/10.1124/dmd.115.065326
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 43 (9)
Drug Metabolism and Disposition
Vol. 43, Issue 9
1 Sep 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • P450 and Non-P450 Oxidative Metabolism
  • Species Differences in Aspirin Hydrolysis in Plasma
  • MODELING OF INTESTINAL DRUG ABSORPTION: ROLES OF TRANSPORTERS AND METABOLIC ENZYMES (FOR THE GILLETTE REVIEW SERIES)
  • SC Absorption of Biotherapeutics
  • An MS-Based Immunoassay Panel for P450s and Transporters
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2018 by the American Society for Pharmacology and Experimental Therapeutics